Projects funded by the NCN
EBI2 receptor as a new myelin repair therapy in multiple sclerosis.
2022/47/D/NZ3/02613
Keywords:
remyelination multiple sclerosis EBI2 (GPR183) cuprizone model organotypic brain slices oligodendrocytes astrocytes microglia
Descriptors:
- NZ3_6: Cell neurobiology
- NZ3_5: Molecular neurobiology
- NZ4_7: Neurophysiology
Panel:
NZ3 - Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution :
Gdański Uniwersytet Medyczny, Centrum Chorób Mózgu
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: SONATA 18 - announced on 2022-07-15
Amount awarded: 1 707 496 PLN
Project start date (Y-m-d): 2023-12-01
Project end date (Y-m-d): 2026-11-30
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.